Let’s talk about something that’s been whispered about for decades: birth control and breast cancer.

Doctors have known for years that hormonal contraceptives — the pill, IUDs, implants, and shots — can slightly increase breast cancer risk. But how much? And does it depend on which kind you use?

A huge new study out of Sweden just took a deep dive into this question — analyzing data from over 2 million women across 21 million years of follow-up. It’s one of the biggest and most detailed looks at the topic ever done.

And here’s what they found: yes, hormonal birth control slightly increases breast cancer risk — but not all types are created equal.

Breaking It Down: The Risk Is Real, But Small

Across all forms of hormonal contraception, the researchers found about 13 extra cases of breast cancer per 100,000 users each year.

So, for the average woman, that’s a very small increase — statistically significant, but not panic-worthy.

The study confirmed that both combined hormonal contraceptives (those with estrogen + progestin) and progestin-only methods (like the mini-pill, implant, or hormonal IUD) were linked to higher risk — but progestin-only forms showed the bigger bump.

In plain English: methods that rely only on synthetic progesterone seem to have a slightly stronger connection to breast cancer.

The Wild Card: Different Hormones, Different Effects

Here’s where things get interesting.

Not all progestins — the synthetic versions of the hormone progesterone — act the same. Some are chemically closer to testosterone, others to progesterone itself. And those tiny molecular differences can change how your body reacts.

In the Swedish study:

  • Levonorgestrel-based methods (found in popular IUDs like Mirena and in some pills) had lower breast cancer risk.
  • Desogestrel-based methods (used in certain mini-pills, combos, and implants) had higher risk.
  • Drospirenone-based pills (like Yaz) didn’t show a significant increase at all.

The difference seems to come down to how these progestins interact with hormone receptors in breast cells. Some versions — like desogestrel — may crank up cell growth signals more than others, while some, like levonorgestrel, may actually temper that response.

Wait — Estrogen Might Not Be the Villain After All?

Surprise twist: estrogen, often blamed for breast cancer risk, may actually dilute some of the harm caused by certain progestins.

When the researchers compared pills with the same progestin but different estrogen levels, they found that the combo pills with more estrogen had lower relative risk than progestin-only versions.

Translation: estrogen might help counterbalance some of the progestin-driven growth activity in breast tissue. (Yeah, hormones are complicated.)

Don’t Panic — Context Matters

Before anyone tosses their IUD in horror, let’s keep the numbers in perspective.

The absolute risk increase is very small. The benefits of birth control — preventing unplanned pregnancies, lowering risk of ovarian and endometrial cancers, managing painful cycles — still far outweigh the risks for most people.

This study just adds more nuance: not all hormonal contraceptives are equal when it comes to long-term breast cancer risk.

The takeaway isn’t “don’t use birth control.” It’s “talk to your doctor about the type that fits your personal health profile best.”

The Bottom Line

  • Hormonal contraceptives slightly raise breast cancer risk — about 13 extra cases per 100,000 women per year.
  • Progestin-only methods show higher risk than combined estrogen-progestin ones.
  • Among progestins, desogestrel had the highest risk bump, levonorgestrel the lowest, and drospirenone looked relatively safe.
  • Estrogen might actually blunt some of progestin’s risk.
  • The study reinforces the need for personalized contraceptive counseling — not one-size-fits-all advice.

Big Picture

This Swedish mega-study doesn’t demonize birth control — it refines our understanding of it. Hormones affect everyone differently, and your pill (or IUD or implant) choice should depend on you — your age, family history, and comfort with risk.

So no, the pill isn’t public enemy #1. But this research is a reminder that when it comes to your health, even the smallest daily doses of hormones can make big differences over time.

Hadizadeh F, Koteci A, Karlsson T, Ek WE, Johansson Å. Hormonal Contraceptive Formulations and Breast Cancer Risk in Adolescents and Premenopausal Women. JAMA Oncol. 2025 Oct 30:e254480. doi: 10.1001/jamaoncol.2025.4480. Epub ahead of print. PMID: 41165687; PMCID: PMC12576617.